News Conference News AHA 2017 Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I Michael O'Riordan November 21, 2017
News Industry News Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure November 14, 2017
Presentation TCT 2017 The Impella Family of Devices: Different Tools for Different Conditions Presenter: Ulrich P. Jorde, Michael Mooney, Hiroo Takayama, Perwaiz M. Meraj November 01, 2017
Presentation TCT 2017 Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience Presenter: Daniel Burkhoff, Samir R. Kapadia, Patrick Klein November 01, 2017
Presentation TCT 2017 First-in-Human Experience With Aortix Intra-aortic Pump Presenter: Daniel Burkhoff, Samir R. Kapadia, Amit N Vora November 01, 2017
Presentation TCT 2017 Therapeutic Force Transduction and Optimization of Intra-cardiac Blood Flow to Support Heart Function in Heart Failure Patients Presenter: Daniel Burkhoff, Samir R. Kapadia, John Wilson November 01, 2017
Presentation TCT 2017 Safety and Efficacy of Percutaneous Axillary Artery Access for Mechanical Circulatory Support With the Impella© Devices: An Initial Evaluation From the Axillary Access Registry to Monitor Safety (ARMS) Multi-center Registry Presenter: Daniel Burkhoff, Samir R. Kapadia, James M. McCabe November 01, 2017
Presentation TCT 2017 First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR) Presenter: Daniel Burkhoff, Samir R. Kapadia, Stephen G. Worthley November 01, 2017
Presentation TCT 2017 First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease Presenter: Daniel Burkhoff, Samir R. Kapadia, Alaide Chieffo November 01, 2017
Presentation TCT 2017 Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies? Presenter: Navin K. Kapur November 01, 2017
Presentation TCT 2017 Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials? Presenter: James E. Udelson November 01, 2017
Presentation TCT 2017 Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials? Presenter: Angeles Alonso Garcia November 01, 2017
Presentation TCT 2017 Ventricular Partitioning Approaches: Surgical and Device-Based Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Jozef Bartunek October 31, 2017
Presentation TCT 2017 State-of-the-Art Overview: Device-Based Therapies for CHF Presenter: Daniel Burkhoff, JoAnn Lindenfeld October 31, 2017
Presentation TCT 2017 US and EU Guidelines for Drug and Device Management of Heart Failure: Overview, Similarities, and Differences Presenter: Daniel Burkhoff, JoAnn Lindenfeld, William T. Abraham October 31, 2017
Presentation TCT 2017 Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy? Presenter: Vladimir Dzavik, Navin K. Kapur, Nicolas M. Van Mieghem October 31, 2017
Presentation TCT 2017 Editorial Perspective: Device-based Neuromodulation and Interventional HF Therapy Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Emerson C. Perin October 31, 2017
Presentation TCT 2017 Soft Robotic Cardiac Assist Device for Heart Failure Patients (CorInnova) Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, William C Altman October 31, 2017